Bioequivalence Trial of Alprazolam 0.25 mg Tablets

NCT01853956 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety Disorders

Interventions

DRUG: Alprazolam 0.25 mg
DRUG: Alprazolam 0.25 mg

Sponsor

GlaxoSmithKline